title: 'Realworld' use of non-vitamin K antagonist oral anticoagulants (NOACs): Lessons from the Dresden NOAC Registry.
authors: John W
authors: JW
authors: Eikelboom
authors: Jeffrey I. Weitz, Thrombosis and Atherosclerosis Research Institute, 237 Barton Street East, Hamilton, Ontario, L8L 2X2, Canada, Tel.: +1 905 574 8550, Fax: +1 905 575 2646, E-mail: weitzj@taari.ca.
authors: Jeffrey I
authors: JI
authors: Weitz
mesh_terms: D000991:Antithrombins / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D000069604:Dabigatran / Q000008:administration & dosage*; D004617:Embolism / Q000517:prevention & control*; D005260:Female; D006801:Humans; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D008297:Male; D020521:Stroke / Q000517:prevention & control*
chemical_list: D000991:Antithrombins; D000069604:Dabigatran